Percutaneous closure of patent foramen ovale with a novel FlatStent™

Expert Review of Medical Devices

Volumn 5, Issue 4, 2008, Pages 419-425

  Reiffenstein, Isabel ^a   Majunke, Nicolas ^a   Wunderlich, Nina ^a   Carter, Phillip ^b   Jones, Ransall ^b   Sievert, Horst ^a,c  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

^b Coherex Medical Inc ^*  (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Closure device; Patent foramen ovale; Stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANATOMY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EQUIPMENT DESIGN; FOLLOW UP; FOREIGN BODY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MIGRAINE; NONHUMAN; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PATIENT SAFETY; RISK REDUCTION; THROMBOEMBOLISM; THROMBOGENESIS; TREATMENT INDICATION; TREATMENT RESPONSE; ANIMAL; HEART CATHETERIZATION; INSTRUMENTATION; PROSTHESIS; RADIOGRAPHY; REVIEW; STENT; STROKE; TREATMENT OUTCOME;

ANIMALS; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MIGRAINE DISORDERS; PROSTHESIS DESIGN; STENTS; STROKE; TREATMENT OUTCOME;

EID: 58149131428     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.5.4.419     Document Type: Article

References (38)

1. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 107(1), 5-9 (2003).
2. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc. 59(1), 17-20 (1984).
3. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J. Am. Coll. Cardiol. 38(3), 613-623 (2001).
4. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and crypto-genic stroke or transient ischemic attack. Am. Heart J. 130(5), 1083-1088 (1995).
5. Germonpre P, Hastir F, Dendale P, Marroni A, Nguyen AF, Balestra C. Evidence for increasing patency of the foramen ovale in divers. Am. J. Cardiol. 95(7), 912-915 (2005).)
6. Chen GP. Patent foramen ovale and the platypnea-orthodeoxia syndrome. Cardiol. Clin. 23(1), 85-89 (2005).
7. Schwerzmann M, Nedeltchev K, Lagger F et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65(9), 1415-1418 (2005).
8. Reisman M, Christofferson RD, Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Cardiol. 45(4), 493-495 (2005).
9. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N. Engl. J. Med. 357, 2262-2268 (2007).
10. Overell JR, Bone, I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55, 1172-1179 (2000).
11. Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med. 345, 1740-1746 (2001).
12. Schuchlenz HW, Weihs W. Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am. J. Med. 109, 456-462 (2000).
13. Meissner I, Khandheria BK, Heit JA et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J. Am. Coll. Cardiol. 47(2), 440-445 (2006).
14. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J. Am. Coll. Cardiol. 49(7), 797-802 (2007).
15. Amarenco P, Cohen A, Tzourio C et al. Atherosclerotic disease of aortic arch and the risk of ischemic stroke. N. Engl. J. Med. 331, 1474-1479 (1994).
16. Steinberg DH, Pichard AD, Satler LF et al. Patent foramen ovale closure: past, present and future. Expert Rev. Cardiovasc. Ther. 5(5), 881-891 (2007).
17. Wilmshurst PT, Nightinqale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet 356(9242), 1648-1651 (2000).
18. Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: a new therapy for migraine. Catheter. Cardiovasc. Interv. 69(2), 277-284 (2007).
19. Lamy C, Giannesini C, Zuber M et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-AS Study. Stroke 33(3), 706-711 (2002).
20. Del Sette M, Angeli S, Leandri M et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case control study. Cerebrovasc. Dis. 8(6), 327-330 (1998).
21. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Wolta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 52(8), 1622-1625 (1999).
22. Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache 47(9), 1311-1318 (2007).
23. Dowson A, Mullen MJ, Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) trial. A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of parent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117, 1397-1404 (2008)
24. Wilmshurst P, Bryson P. Relationship between the clinical features of neurological decompression illness and its causes. Clin. Sci. (Lond.) 99, 65-75 (2000).
25. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J. Interv. Cardiol. 16, 39-42 (2003).
26. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt associated migraine responds favorably to atrial septal repair: a case control study. Stroke. 37, 430-434 (2006).
27. Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc. Interv. 69, 740-746 (2007).
28. Rigatelli G, Cardaioli P, Braggion G et al. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc. Interv. 70, 429-433 (2007).
29. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 66, 765-767 (2006).
30. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of parent foramen ovale after presumed paradoxical embolism. Circulation 86(6), 1902-1908 (1992).
31. Schwerzmann M, Windecker S, Wahl A et al. Percutaneous closure of patent foramen ovule: impact of device on safety and efficacy. Heart90(2), 186-190 (2004).
32. Mullen MJ, Hildick-Smith D, De Giovanni JV et al. BioSTAR Evaluation Study (BEST): a prospective, multicenter, Phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 114(18), 1962-1967 (2006).
33. Windecker S, Wahl A, Chatterjee T et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long term risk of recurrent thromboembolic events. Circulation 101(8), 893-898 (2000).
34. Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc. Interv. 68(5), 741-746 (2006).
35. Alameddine F, Block PC. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc. Interv. 62(4), 512-516 (2004).
36. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J. Am. Coll. Cardiol. 48(1), 161-169 (2006).
37. Jux C, Wohlsein P, Bruegmann M, Zutz M, Franzbach B, Bertram H. A new biological matrix for septal occlusion. J. Interv. Cardiol. 16(2), 149-152 (2003).
38. Büscheck F, Sievert H, Kleber F et al. Patent foramen ovale using the Premere device: the results of the CLOSEUP trial. J. Interv. Cardiol. 19(4), 328-333 (2006).